Vir Biotechnology, Inc.

SEC 4 · Filed

0001628280-26-020480Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 20, 2026

Other transaction by O'Byrne Jason

Security
Common Stock
Code
J
Shares
2,500
Price per share
0.00
Structured facts
{
  "code": "J",
  "date": "2026-03-20",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transfer without consideration for estate planning purposes.",
    "F2": "The shares are held in the name of the O\u0027Byrne Family Trust, of which the Reporting Person and his spouse are Trustees."
  },
  "owners": [
    {
      "cik": "0001871145",
      "name": "O\u0027Byrne Jason",
      "roles": [
        "officer"
      ],
      "title": "EVP \u0026 Chief Financial Officer"
    }
  ],
  "ownership": "I",
  "post_shares": "2500",
  "price": "0",
  "row": 2,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "2500",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Mar 20, 2026

Other transaction by O'Byrne Jason

Security
Common Stock
Code
J
Shares
2,500
Price per share
0.00
Structured facts
{
  "code": "J",
  "date": "2026-03-20",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transfer without consideration for estate planning purposes."
  },
  "owners": [
    {
      "cik": "0001871145",
      "name": "O\u0027Byrne Jason",
      "roles": [
        "officer"
      ],
      "title": "EVP \u0026 Chief Financial Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "160115",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "2500",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}